Lab investigates heartburn drug’s possible cancer link

The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the Food and Drug Administration. A lab in California has also been working to get to the bottom of its potential dangers. First on “CBS This Morning” Dr. Jon LaPook has a look inside that lab. Source